Search

Search Constraints

You searched for: Author/Creator Hall, Coleen

Search Results

1. Change in the hepatic profile of hepatitis C virus genotype 4–infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE‐II study. Issue 11 (16th July 2018)

3. Effect of Levodopa‐carbidopa Intestinal Gel on Non‐motor Symptoms in Patients with Advanced Parkinson's Disease. Issue 6 (20th September 2017)

5. Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease. Issue 6 (23rd March 2018)

6. Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial. Issue 9986 (20th June 2015)

7. Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial. (September 2016)

9. Updated long-term safety from ongoing phase 3 trials of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease. (January 2016)